Table 1.
Participant Characteristics | ||
---|---|---|
(N = 361 participants) | ||
Female, N (%) | 183 | (50.7) |
Age (yr.), Median (IQR) | 62 | (53, 69) |
Race/Ethnicity, N (%) | ||
White | 242 | (67.0) |
Black/African American | 68 | (18.8) |
Hispanic or Latino | 33 | (9.1) |
Asian | 10 | (2.8) |
Native Hawaiian/Other Pacific Islander | 1 | (0.3) |
More than one race | 3 | (0.8) |
Unknown/not reported | 4 | (1.1) |
Diabetes type, N (%) | ||
Type 1 | 49 | (13.6) |
Type 2 | 307 | (85.0) |
Uncertain | 5 | (1.4) |
Duration of diabetes (yr.), Median (IQR) | 20 | (13, 28) |
HbA1c (%), Median (IQR) * | 7.9 | (7.0, 9.0) |
Mean arterial pressure (mmHg), Median (IQR) | 97 | (90, 106) |
Bilateral participant, N (%) | 186 | (51.5) |
Ocular Characteristics | ||
(N = 652 eyes) | ||
Study eyes, N (%) | 529 | (81.1) |
Visual acuity (letter score), Median (IQR) | 85 | (81, 89) |
~Snellen equivalent, Median (IQR) | 20/20 | (20/25, 20/16) |
DR severity assessed within the ETDRS 7-fields on UWF-color, N (%) | ||
DR Absent (Level 10/12) | 3 | (0.5) |
DR Questionable or Microaneurysms Only (Level 14/15/20) | 4 | (0.6) |
Mild NPDR (Level 35) | 200 | (30.7) |
Moderate NPDR (Level 43) | 157 | (24.1) |
Moderately Severe NPDR (Level 47) | 91 | (14.0) |
Severe and Very Severe NPDR (Level 53) | 167 | (25.6) |
Inactive PDR or Mild PDR (Level 60/61) | 12 | (1.8) |
Moderate PDR (Level 65) | 12 | (1.8) |
High-risk PDR (Level 71/75) | 6 | (0.9) |
DME severity based on UWF-color, N (%) | ||
No DME | 401 | (61.5) |
Questionable DME | 4 | (0.6) |
Less than clinically significant macular edema | 175 | (26.8) |
Clinically significant macular edema | 61 | (9.4) |
Ungradable | 11 | (1.7) |
OCT central subfield thickness (Stratus equivalent, μm), Median (IQR)† | 213 | (195, 234) |
Phakic lens status on clinical examination, N (%) | 479 | (73.5) |
HbA1c unavailable for 6 participants
Central subfield thickness unavailable for 1 eye
IQR, interquartile range; DR, diabetic retinopathy; ETDRS, Early Treatment Diabetic Retinopathy Study; UWF, ultrawide field; NPDR, non-proliferative diabetic retinopathy; PDR, proliferative diabetic retinopathy; DME, diabetic macular edema; OCT, optical coherence tomography.